Today’s stock pick update – Open Now

Learn More

Sponsored 2021 Investor Alert: Amazon, Google, And Facebook Stockpile Strange Gas This odorless, colorless gas is critical for every piece of technology you own. However, the world's supply is running dangerously low. This is the time for investors to get in before the mainstream media. Click HERE To See Why Big Tech Is Hoarding This Gas

Immunotherapies, Amplifiers, Digital Printing, Electric Mobility, Clinical Research BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer. Read More ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. Read More GNTX has an interesting niche in the Auto Components industry and a strong upward trend – is it a good value? There are a lot of ways to find new candidates that might be useful for keeping your money working for you, and I’ve learned not to dismiss any of them too quickly. From water cooler talk with a friend or colleague, to looking up the company that makes a favored brand, or even to listening to talking heads on market news media offer their opinions about current market conditions, they can all be useful in uncovering new places to put your money to work. It’s true that, oftentimes you shou... Read More

Featured Stock Greenhill & Co., Inc. (GHL) – Buy Price: $19.00 or better Greenhill & Co., Inc., an independent investment bank, provides financial and strategic advisory services to corporations, partnerships, institutions, and governments worldwide. The company offers advisory services related to mergers and acquisitions, divestitures, spin-offs, and other strategic transactions, as well as various stages of a transaction’s life cycle ranging from initial structuring and negotiation to final execution. Read More

Sponsored 3 Hot Biotech Breakthroughs to Bank On Now… and Why Biotech breakthroughs by nature are part of incredibly innovative companies that are disruptors that are redefining the world we live in. And right now, the stocks working hardest toward transformational therapies… and that means some of the biggest opportunities for investors right now. In my latest research report, I share my insights on the biotech sector and give you the names of my top 3 picks. Download your FREE copy today!   Additional Sponsored Content This “Moneymaking” Algorithm Could Alert You To Buy Or Sell Stocks Just Before A Crash (Privacy Policy/Disclosures) This Secret Roadmap Shows Smart Traders When To Buy Or Sell To Lock In Profits Of Over 1000% *(Clicking automatically opts you into Precision Volume Alerts newsletter) (Privacy Policy/Disclosures)

Already subscribed to our premium service? Click here to Login Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

This email was sent to indra21poetra@gmail.com from Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037 Unsubscribe Disclaimers, Terms & Conditions Privacy Policy Copyright 2021

Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.